{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:55:18Z","timestamp":1773827718872,"version":"3.50.1"},"reference-count":37,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,16]]},"DOI":"10.20945\/2359-3997000000437","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T14:34:13Z","timestamp":1647527653000},"source":"Crossref","is-referenced-by-count":4,"title":["Differences in hormonal levels between heterozygous CYP21A2 pathogenic variant carriers, non-carriers, and females with non-classic congenital hyperplasia"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0338-3399","authenticated-orcid":false,"given":"Rita Santos","family":"Silva","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5119-5341","authenticated-orcid":false,"given":"Berta","family":"Carvalho","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1141-4538","authenticated-orcid":false,"given":"Jorge","family":"Pedro","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5967-0231","authenticated-orcid":false,"given":"C\u00edntia","family":"Castro-Correia","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3156-3741","authenticated-orcid":false,"given":"Davide","family":"Carvalho","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9546-4614","authenticated-orcid":false,"given":"Filipa","family":"Carvalho","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6990-4583","authenticated-orcid":false,"given":"Manuel","family":"Fontoura","sequence":"additional","affiliation":[]}],"member":"8510","reference":[{"issue":"2","key":"key20220317103334_B1","first-page":"241","article-title":"Clinical review 54: Genetics, diagnosis, and management of 21-hydroxylase deficiency","volume":"78","author":"Miller","year":"1994","unstructured":"1 Miller WL. Clinical review 54: Genetics, diagnosis, and management of 21-hydroxylase deficiency. J Clin Endocrinol Metab. 1994;78(2):241-6.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key20220317103334_B2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1210\/jc.2004-1728","article-title":"Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population","volume":"90","author":"Baumgartner-Parzer","year":"2005","unstructured":"2 Baumgartner-Parzer SM, Nowotny P, Heinze G, Waldhausl W, Vierhapper H. Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population. J Clin Endocrinol Metab. 2005;90(2):775-8.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key20220317103334_B3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000497485","article-title":"CYP21A2 Gene Pathogenic Variants: A Multicenter Study on Genotype-Phenotype Correlation from a Portuguese Pediatric Cohort","volume":"91","author":"Santos-Silva","year":"2019","unstructured":"3 Santos-Silva R, Cardoso R, Lopes L, Fonseca M, Espada F, Sampaio L, et al. CYP21A2 Gene Pathogenic Variants: A Multicenter Study on Genotype-Phenotype Correlation from a Portuguese Pediatric Cohort. Horm Res Paediatr. 2019;91(1):33-45.","journal-title":"Horm Res Paediatr"},{"issue":"11","key":"key20220317103334_B4","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline","volume":"103","author":"Speiser","year":"2018","unstructured":"4 Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP, et al. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(11):4043-88.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key20220317103334_B5","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1210\/jcem.84.5.5683","article-title":"High incidence of molecular defects of the CYP21 gene in patients with premature adrenarche","volume":"84","author":"Dacou-Voutetakis","year":"1999","unstructured":"5 Dacou-Voutetakis C, Dracopoulou M. High incidence of molecular defects of the CYP21 gene in patients with premature adrenarche. J Clin Endocrinol Metab. 1999;84(5):1570-4.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20220317103334_B6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1530\/acta.0.112S284","article-title":"Is heterozygosity for the steroid 21-hydroxylase deficiency responsible for hirsutism, premature pubarche, early puberty, and precocious puberty in children?","volume":"279","author":"Knorr","year":"1986","unstructured":"6 Knorr D, Bidlingmaier F, H\u00f6ller W, Kuhnle U, Meiler B, Nachmann A. Is heterozygosity for the steroid 21-hydroxylase deficiency responsible for hirsutism, premature pubarche, early puberty, and precocious puberty in children? Acta Endocrinol Suppl (Copenh). 1986;279:284-9.","journal-title":"Acta Endocrinol Suppl (Copenh)"},{"issue":"5","key":"key20220317103334_B7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/09513590903511505","article-title":"Premature pubarche in Mediterranean girls: high prevalence of heterozygous CYP21 mutation carriers","volume":"26","author":"Paris","year":"2010","unstructured":"7 Paris F, Tardy V, Chalan\u00e7on A, Picot MC, Morel Y, Sultan C. Premature pubarche in Mediterranean girls: high prevalence of heterozygous CYP21 mutation carriers. Gynecol Endocrinol. 2010;26(5):319-24.","journal-title":"Gynecol Endocrinol"},{"key":"key20220317103334_B8","first-page":"768506","article-title":"Prevalence of nonclassic congenital adrenal hyperplasia in Turkish children presenting with premature pubarche, hirsutism, or oligomenorrhoea","author":"Binay","year":"2014","unstructured":"8 Binay C, Simsek E, Cilingir O, Yuksel Z, Kutlay O, Artan S. Prevalence of nonclassic congenital adrenal hyperplasia in Turkish children presenting with premature pubarche, hirsutism, or oligomenorrhoea. Int J Endocrinol. 2014;768506.","journal-title":"Int J Endocrinol"},{"key":"key20220317103334_B9","first-page":"1315","article-title":"The role of heterozygosity for CYP21 in the polycystic ovary syndrome","volume":"13","author":"Witchel","year":"2000","unstructured":"9 Witchel SF, Aston CE. The role of heterozygosity for CYP21 in the polycystic ovary syndrome. J Pediatr Endocrinol Metab. 2000;13 Suppl 5:1315-7.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"key20220317103334_B10","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0002-9378(95)90021-7","article-title":"Molecular abnormalities of the 21-hydroxylase gene in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to short-term adrenal stimulation","volume":"172","author":"Azziz","year":"1995","unstructured":"10 Azziz R, Owerbach D. Molecular abnormalities of the 21-hydroxylase gene in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to short-term adrenal stimulation. Am J Obstet Gynecol. 1995;172(3):914-8.","journal-title":"Am J Obstet Gynecol"},{"key":"key20220317103334_B11","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.4103\/2230-8210.145077","article-title":"Phenotypic variability of hyperandrogenemia in females heterozygous for CYP21A2 mutations","volume":"18","author":"Neocleous","year":"2014","unstructured":"11 Neocleous V, Shammas C, Phedonos A, Phylactou L, Skordis N. Phenotypic variability of hyperandrogenemia in females heterozygous for CYP21A2 mutations. Indian J Endocrinol Metab. 2014;18:S72-9.","journal-title":"Indian J Endocrinol Metab"},{"issue":"3","key":"key20220317103334_B12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s12020-019-02104-7","article-title":"The prevalence of heterozygous CYP21A2 deficiency in patients with idiopathic acne, hirsutism, or both","volume":"67","author":"Gao","year":"2020","unstructured":"12 Gao Y, Yu B, Mao J, Wang X, Nie M, Wu X. The prevalence of heterozygous CYP21A2 deficiency in patients with idiopathic acne, hirsutism, or both. Endocrine. 2020;67(3):665-72.","journal-title":"Endocrine"},{"issue":"3","key":"key20220317103334_B13","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1210\/jc.2004-1214","article-title":"Significantly higher adrenocorticotropin-stimulated cortisol and 17-hydroxyprogesterone levels in 337 consecutive, premenopausal, caucasian, hirsute patients compared with healthy controls","volume":"90","author":"Glintborg","year":"2005","unstructured":"13 Glintborg D, Hermann AP, Brusgaard K, Hangaard J, Hagen C, Andersen M. Significantly higher adrenocorticotropin-stimulated cortisol and 17-hydroxyprogesterone levels in 337 consecutive, premenopausal, caucasian, hirsute patients compared with healthy controls. J Clin Endocrinol Metab. 2005;90(3):1347-53.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key20220317103334_B14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-2008-1081209","article-title":"The frequency of CYP 21 gene mutations in Turkish women with hyperandrogenism","volume":"117","author":"Kelestimur","year":"2009","unstructured":"14 Kelestimur F, Everest H, Dundar M, Tanriverdi F, White C, Witchel SF. The frequency of CYP 21 gene mutations in Turkish women with hyperandrogenism. Exp Clin Endocrinol Diabetes. 2009;117(5):205-8.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"4","key":"key20220317103334_B15","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0015-0282(00)01798-2","article-title":"Candidate gene analysis in premature pubarche and adolescent hyperandrogenism","volume":"75","author":"Witchel","year":"2001","unstructured":"15 Witchel SF, Smith R, Tomboc M, Aston CE. Candidate gene analysis in premature pubarche and adolescent hyperandrogenism. Fertil Steril. 2001;75(4):724-30.","journal-title":"Fertil Steril"},{"issue":"1","key":"key20220317103334_B16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s004390050586","article-title":"Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women","volume":"101","author":"Blanch\u00e9","year":"1997","unstructured":"16 Blanch\u00e9 H, Vexiau P, Clauin S, Le Gall I, Fiet J, Mornet E, et al. Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women. Hum Genet. 1997;101(1):56-60.","journal-title":"Hum Genet"},{"issue":"2","key":"key20220317103334_B17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/bmme.1997.2632","article-title":"Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency","volume":"62","author":"Witchel","year":"1997","unstructured":"17 Witchel SF, Lee PA, Suda-Hartman M, Hoffman EP. Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency. Biochem Mol Med. 1997;62(2):151-8.","journal-title":"Biochem Mol Med"},{"issue":"2","key":"key20220317103334_B18","first-page":"479","article-title":"Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism","volume":"82","author":"Knochenhauer","year":"1997","unstructured":"18 Knochenhauer ES, Cortet-Rudelli C, Cunnigham RD, Conway-Myers BA, Dewailly D, Azziz R. Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism. J Clin Endocrinol Metab. 1997;82(2):479-85.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key20220317103334_B19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0015-0282(99)00317-9","article-title":"The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations","volume":"72","author":"Escobar-Morreale","year":"1999","unstructured":"19 Escobar-Morreale HF, San Millan JL, Smith RR, Sancho J, Witchel SF. The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations. Fertil Steril. 1999;72(4):629-38.","journal-title":"Fertil Steril"},{"issue":"4","key":"key20220317103334_B20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1530\/eje.0.1470485","article-title":"Molecular defects of the CYP21 gene in Spanish girls with isolated precocious pubarche","volume":"147","author":"Potau","year":"2002","unstructured":"20 Potau N, Rique S, Eduardo I, Marcos V, Ibanez L. Molecular defects of the CYP21 gene in Spanish girls with isolated precocious pubarche. Eur J Endocrinol. 2002;147(4):485-8.","journal-title":"Eur J Endocrinol"},{"key":"key20220317103334_B21","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jsbmb.2014.06.004","article-title":"Premature adrenarche: etiology, clinical findings, and consequences","volume":"145","author":"Voutilainen","year":"2015","unstructured":"21 Voutilainen R, Jaaskelainen J. Premature adrenarche: etiology, clinical findings, and consequences. J Steroid Biochem Mol Biol. 2015;145:226-36.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"7","key":"key20220317103334_B22","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","article-title":"Hirsutism: implications, etiology, and management","volume":"140","author":"Hatch","year":"1981","unstructured":"22 Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 1981;140(7):815-30.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"key20220317103334_B23","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2265.2006.02465.x","article-title":"High variability in CYP21A2 mutated alleles in Spanish 21-hydroxylase deficiency patients, six novel mutations and a founder effect","volume":"64","author":"Loidi","year":"2006","unstructured":"23 Loidi L, Quinteiro C, Parajes S, Barreiro J, Leston DG, Cabezas-Agricola JM, et al. High variability in CYP21A2 mutated alleles in Spanish 21-hydroxylase deficiency patients, six novel mutations and a founder effect. Clin Endocrinol (Oxf). 2006;64(3):330-6.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"key20220317103334_B24","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1055\/s-0032-1323805","article-title":"Comprehensive genetic analysis and structural characterization of CYP21A2 mutations in CAH patients","volume":"120","author":"Carvalho","year":"2012","unstructured":"24 Carvalho B, Pereira M, Marques CJ, Carvalho D, Leao M, Oliveira JP, et al. Comprehensive genetic analysis and structural characterization of CYP21A2 mutations in CAH patients. Exp Clin Endocrinol Diabetes. 2012;120(9):535-9.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"2","key":"key20220317103334_B25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2265.1998.3811205.x","article-title":"Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acne","volume":"48","author":"Ostlere","year":"1998","unstructured":"25 Ostlere LS, Rumsby G, Holownia P, Jacobs HS, Rustin MH, Honour JW. Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acne. Clin Endocrinol (Oxf). 1998;48(2):209-15.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"key20220317103334_B26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1530\/EJE-14-1084","article-title":"LC-MS\/MS based determination of basal- and ACTH-stimulated plasma concentrations of 11 steroid hormones: implications for detecting heterozygote CYP21A2 mutation carriers","volume":"173","author":"Kulle","year":"2015","unstructured":"26 Kulle AE, Riepe FG, Hedderich J, Sippell WG, Schmitz J, Niermeyer L, et al. LC-MS\/MS based determination of basal- and ACTH-stimulated plasma concentrations of 11 steroid hormones: implications for detecting heterozygote CYP21A2 mutation carriers. Eur J Endocrinol. 2015;173(4):517-24.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"key20220317103334_B27","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2265.2006.02521.x","article-title":"Hyperandrogenism in carriers of CYP21 mutations: the role of genotype","volume":"64","author":"Admoni","year":"2006","unstructured":"27 Admoni O, Israel S, Lavi I, Gur M, Tenenbaum-Rakover Y. Hyperandrogenism in carriers of CYP21 mutations: the role of genotype. Clin Endocrinol (Oxf). 2006;64(6):645-51.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"key20220317103334_B28","first-page":"498","article-title":"Correlation between genotype and hormonal levels in heterozygous mutation carriers and non-carriers of 21-hydroxylase deficiency","volume":"34","author":"Napolitano","year":"2011","unstructured":"28 Napolitano E, Manieri C, Restivo F, Composto E, Lanfranco F, Repici M, et al. Correlation between genotype and hormonal levels in heterozygous mutation carriers and non-carriers of 21-hydroxylase deficiency. J Endocrinol Invest. 2011;34(7):498-501.","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"key20220317103334_B29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1586\/eem.13.18","article-title":"Nonclassic congenital adrenal hyperplasia and the heterozygote carrier","volume":"8","author":"Ahmadi","year":"2013","unstructured":"29 Ahmadi S, Alvi S, Urban RJ. Nonclassic congenital adrenal hyperplasia and the heterozygote carrier. Expert Rev Endocrinol Metab. 2013;8(3):239-46.","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"5","key":"key20220317103334_B30","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0015-0282(99)00383-0","article-title":"Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study","volume":"72","author":"Azziz","year":"1999","unstructured":"30 Azziz R, Hincapie LA, Knochenhauer ES, Dewailly D, Fox L, Boots LR. Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. Fertil Steril. 1999;72(5):915-25.","journal-title":"Fertil Steril"},{"issue":"7","key":"key20220317103334_B31","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1515\/JPEM.2003.16.7.1017","article-title":"Steroid 21-hydroxylase (P450c21) naturally occurring mutants I172N, V281L and I236n\/V237E\/M239K exert a dominant negative effect on enzymatic activity when co-expressed with the wild-type protein","volume":"16","author":"F\u00e9lix-L\u00f3pez","year":"2003","unstructured":"31 F\u00e9lix-L\u00f3pez X, Riba L, Ord\u00f3\u00f1ez-S\u00e1nchez ML, Ram\u00edrez-Jim\u00e9nez S, Ventura-Gallegos JL, Zentella-Dehesa A, et al. Steroid 21-hydroxylase (P450c21) naturally occurring mutants I172N, V281L and I236n\/V237E\/M239K exert a dominant negative effect on enzymatic activity when co-expressed with the wild-type protein. J Pediatr Endocrinol Metab. 2003;16(7):1017-24.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"key20220317103334_B32","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1210\/jcem.87.2.8247","article-title":"Variable ACTH-stimulated 17-hydroxyprogesterone values in 21-hydroxylase deficiency carriers are not related to the different CYP21 gene mutations","volume":"87","author":"Bachega","year":"2002","unstructured":"32 Bachega, TA, Brenlha EM, Billerbeck AE, Marcondes JA, Madureira G, Arnhold IJ, et al. Variable ACTH-stimulated 17-hydroxyprogesterone values in 21-hydroxylase deficiency carriers are not related to the different CYP21 gene mutations. J Clin Endocrinol Metab. 2002;87(2):786-90.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"key20220317103334_B33","first-page":"4081","article-title":"Phenotypic heterogeneity associated with the splicing mutation in congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"81","author":"Witchel","year":"1996","unstructured":"33 Witchel SF, Bhamidipati DK, Hoffman EP, Cohen JB. Phenotypic heterogeneity associated with the splicing mutation in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 1996;81(11):4081-8.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20220317103334_B34","first-page":"8984365","article-title":"Variations in the 3\u2019UTR of the CYP21A2 Gene in Heterozygous Females with Hyperandrogenaemia","author":"Neocleous","year":"2017","unstructured":"34 Neocleous V, Fanis P, Toumba M, Phedonos AAP, Picolos M, Andreou E, et al. Variations in the 3\u2019UTR of the CYP21A2 Gene in Heterozygous Females with Hyperandrogenaemia. Int J Endocrinol. 2017;8984365-8984365.","journal-title":"Int J Endocrinol"},{"issue":"1","key":"key20220317103334_B35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/rcm.1284","article-title":"Analysis of 21-deoxycortisol, a marker of congenital adrenal hyperplasia, in blood by atmospheric pressure chemical ionization and electrospray ionization using multiple reaction monitoring","volume":"18","author":"Cristoni","year":"2004","unstructured":"35 Cristoni S, Cuccato D, Sciannamblo M, Bernardi LR, Biunno I, Gerthoux P, et al. Analysis of 21-deoxycortisol, a marker of congenital adrenal hyperplasia, in blood by atmospheric pressure chemical ionization and electrospray ionization using multiple reaction monitoring. Rapid Commun Mass Spectrom. 2004;18(1):77-82.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"key20220317103334_B36","first-page":"1","article-title":"Congenital Adrenal Hyperplasia: Time to Replace 17OHP with 21Deoxycortisol","volume":"26","author":"Miller","year":"2019","unstructured":"36 Miller WL. Congenital Adrenal Hyperplasia: Time to Replace 17OHP with 21Deoxycortisol. Horm Res Paediatr. 2019;26:1-5.","journal-title":"Horm Res Paediatr"},{"key":"key20220317103334_B37","doi-asserted-by":"crossref","first-page":"105554","DOI":"10.1016\/j.jsbmb.2019.105554","article-title":"Clinical and hormonal characteristics in heterozygote carriers of congenital hyperplasia","volume":"198","author":"Guarnotta","year":"2020","unstructured":"37 Guarnotta V, Niceta M, Bono M, Marchese S, Fabiano C, Indelicato S, et al. Clinical and hormonal characteristics in heterozygote carriers of congenital hyperplasia. J Steroid Biochem Mol Biol. 2020;198:105554.","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T14:34:53Z","timestamp":1647527693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/differences-in-hormonal-levels-between-heterozygous-cyp21a2-pathogenic-variant-carriers-non-carriers-and-females-with-non-classic-congenital-hyperplasia\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":37,"alternative-id":["10.20945\/2359-3997000000437"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000437","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]}}}